Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kina...
Leadership
Gary D. Glick Ph.D.Founder
Founder, President, CEO & Director
Jason Haas M.B.A.
Chief Financial Officer
Collin Todd
Senior Vice President of Strategy & Business Development
